Online citations, reference lists, and bibliographies.

Current Controversies In The Surgical Management Of Pancreatic Cancer

Ammar A. Javed, Kanza Aziz, Christopher L. Wolfgang
Published 2016 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Pancreatic ductal adenocarcinoma is one of the deadliest malignancies with an extremely poor survival rate. Both environmental and hereditary factors play a role in the development of disease, and early diagnosis is difficult due to early systemic involvement of disease. Thus, a majority of patients are not surgical candidates at the time of diagnosis.
This paper references
10.1016/j.semradonc.2010.11.004
The promise and pitfalls of positron emission tomography and single-photon emission computed tomography molecular imaging-guided radiation therapy.
R. Wahl (2011)
10.1016/S0006-3495(90)82348-1
Changes in membrane structure induced by electroporation as revealed by rapid-freezing electron microscopy.
D. Chang (1990)
10.1158/0008-5472.CAN-09-0015
Genetic mutations associated with cigarette smoking in pancreatic cancer.
A. Blackford (2009)
10.1136/oem.57.5.316
Occupational exposures and pancreatic cancer: a meta-analysis
I. A. Ojajärvi (2000)
10.1186/1471-2407-10-569
Pancreatic cancer and depression: myth and truth
M. Mayr (2010)
Value of laparoscopy in the staging of pancreatic cancer.
D. Camacho (2005)
10.1093/oxfordjournals.aje.a114972
Life-style risk factors for pancreatic cancer in Louisiana: a case-control study.
R. Falk (1988)
10.1007/BF02924156
Reported family aggregation of pancreatic cancer within a population-based case-control study in the francophone community in Montreal, Canada
P. Ghadirian (1991)
10.1097/00000658-199502000-00005
Carcinoma of the Pancreatic Head and Periampullary Region Tumor Staging with Laparoscopy and Laparoscopic Ultrasonography
T. John (1995)
10.1002/bjs.4484
Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma
M. Wagner (2004)
10.1002/bjs.6049
Genetic susceptibility in pancreatic ductal adenocarcinoma
R. Lochan (2008)
10.1016/j.gassur.2004.09.046
Pancreaticoduodenectomy with vascular resection: margin status and survival duration
J. Tseng (2007)
10.1097/SLA.0b013e318190a6da
Neoadjuvant Chemotherapy Generates a Significant Tumor Response in Resectable Pancreatic Cancer Without Increasing Morbidity: Results of a Prospective Phase II Trial
Stefan Heinrich (2008)
10.1016/B978-0-443-06694-8.50089-0
Carcinoma of the Pancreas
Jeffrey Adam Drebin (2008)
10.1097/00000658-200201000-00001
Utility of Staging Laparoscopy in Subsets of Peripancreatic and Biliary Malignancies
C. Vollmer (2002)
10.1007/s00268-002-6659-z
Long-term Results of Partial Pancreaticoduodenectomy for Ductal Adenocarcinoma of the Pancreatic Head: 25-Year Experience
A. Richter (2003)
10.1245/s10434-008-9992-0
PET/CT Fusion Scan Enhances CT Staging in Patients with Pancreatic Neoplasms
J. Farma (2008)
10.3322/caac.21166
Cancer statistics, 2013
R. Siegel (2013)
10.6004/JNCCN.2012.0073
Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines.
M. Tempero (2012)
10.1093/annonc/mdr541
Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4).
C. Bosetti (2012)
10.1053/j.seminoncol.2014.12.003
Diagnostic evaluation and staging of pancreatic ductal adenocarcinoma.
Caitlin A McIntyre (2015)
10.1245/s10434-008-9929-7
Evaluating the Impact of a Single-Day Multidisciplinary Clinic on the Management of Pancreatic Cancer
T. Pawlik (2008)
10.3978/j.issn.2227-684X.2013.02.02
Cryosurgery for pancreatic cancer.
Kecheng Xu (2013)
10.1053/J.GASTRO.2005.05.007
Probability of pancreatic cancer following diabetes: a population-based study.
S. Chari (2005)
10.1097/00000658-199602000-00004
The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy.
K. Conlon (1996)
10.1038/sj.bjc.6602619
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
R. Huxley (2005)
10.4103/1947-2714.106183
Laparoscopic Staging and Surgical Treatment of Pancreatic Cancer
Thiruvengadam Muniraj (2013)
10.1016/j.rcl.2012.03.008
Imaging of pancreatic adenocarcinoma: update on staging/resectability.
E. Tamm (2012)
10.1200/JCO.2007.15.8642
Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head.
G. Varadhachary (2008)
10.3322/caac.21149
Cancer treatment and survivorship statistics, 2012
R. Siegel (2012)
10.1001/jama.2010.1275
Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.
J. Neoptolemos (2010)
10.1002/bjs.6800
Feasibility and safety of radiofrequency ablation for locally advanced pancreatic cancer
R. Girelli (2010)
10.1016/j.ijrobp.2009.06.049
18Fluorodeoxyglucose PET is prognostic of progression-free and overall survival in locally advanced pancreas cancer treated with stereotactic radiotherapy.
D. Schellenberg (2010)
10.3322/caac.21208
Cancer statistics, 2014
R. Siegel (2014)
10.1016/S1072-7515(01)00878-X
Staging laparoscopy with laparoscopic ultrasonography: optimizing resectability in hepatobiliary and pancreatic malignancy.
M. Callery (1997)
Diagnosis and management of pancreatic cancer.
M. S. D. de la Cruz (2014)
10.1200/JCO.2007.12.0592
Phase I study of oxaliplatin, full-dose gemcitabine, and concurrent radiation therapy in pancreatic cancer.
S. Desai (2007)
Pancreatic carcinoma: differences between patients with or without diabetes mellitus.
C. Girelli (1995)
10.1245/s10434-011-2211-4
Defined Clinical Classifications Are Associated with Outcome of Patients with Anatomically Resectable Pancreatic Adenocarcinoma Treated with Neoadjuvant Therapy
Ching-Wei D. Tzeng (2011)
10.1016/j.jvir.2013.07.005
Microwave ablation of pancreatic head cancer: safety and efficacy.
G. Carrafiello (2013)
10.1200/JCO.2007.15.5556
Prospective phase II trial of neoadjuvant chemotherapy with gemcitabine and cisplatin for resectable adenocarcinoma of the pancreatic head.
S. Heinrich (2008)
10.1159/000320068
Epidemiology of Pancreatic Cancer: An Update
P. Maisonneuve (2010)
10.1245/s10434-009-0408-6
Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement
M. Callery (2009)
10.3748/WJG.V16.I7.818
Vascular invasion in pancreatic cancer: Imaging modalities, preoperative diagnosis and surgical management.
N. Buchs (2010)
10.1097/COC.0000000000000022
Longer Course of Induction Chemotherapy Followed by Chemoradiation Favors Better Survival Outcomes for Patients With Locally Advanced Pancreatic Cancer
F. Faisal (2016)
10.1007/s00066-014-0737-7
Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer
Henriette M B Golcher (2014)
10.1200/JCO.2007.15.8634
Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head.
D. Evans (2008)
10.1016/S1091-255X(01)00004-X
Diagnostic laparoscopy for periampullary and pancreatic cancer: What is the true benefit?
C. Barreiro (2002)
10.1016/j.jamcollsurg.2007.09.021
Current utility of staging laparoscopy for pancreatic and peripancreatic neoplasms.
R. White (2008)
10.3322/caac.21190
Recent progress in pancreatic cancer
C. Wolfgang (2013)
10.1097/COC.0b013e318172d5c5
Histopathological Response to Preoperative Chemoradiation for Resectable Pancreatic Adenocarcinoma: The French Phase II FFCD 9704-SFRO Trial
R. Le Scodan (2008)
10.1007/s11605-014-2620-3
Does the Use of Neoadjuvant Therapy for Pancreatic Adenocarcinoma Increase Postoperative Morbidity and Mortality Rates?
A. Cooper (2014)
10.1001/archinternmed.2010.63
Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan).
A. Arslan (2010)
10.1002/1097-0142(19850715)56:2<397::AID-CNCR2820560232>3.0.CO;2-I
Pancreatic cancer. Assessment of prognosis by clinical presentation
M. Kalser (1985)
10.1136/pgmj.2010.098350
Tumour cryoablation combined with palliative bypass surgery in the treatment of unresectable pancreatic cancer: a retrospective study of 142 patients
Jingdong Li (2010)
10.1093/jnci/djn428
Adjuvant chemoradiation for pancreatic cancer: few good data, much debate.
Renée Twombly (2008)
10.1007/s00423-006-0098-5
Radiofrequency ablation combined with palliative surgery may prolong survival of patients with advanced cancer of the pancreas
J. Spiliotis (2006)
10.1371/journal.pmed.1000267
Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
S. Gillen (2010)
10.1002/bem.20692
Microsecond and nanosecond electric pulses in cancer treatments.
M. Breton (2012)
10.1002/ijc.25148
Family history of cancer and risk of pancreatic cancer: A pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan)
E. Jacobs (2010)
10.1053/J.GASTRO.2005.03.035
Surgery for pancreatic cancer: recent controversies and current practice.
C. Wray (2005)
10.1093/jnci/djp466
Importance of Age of Onset in Pancreatic Cancer Kindreds
K. Brune (2010)
10.1111/j.1443-9573.2007.00322.x
Cryosurgery with combination of 125iodine seed implantation for the treatment of locally advanced pancreatic cancer
Ke Xu (2008)
10.1097/00002820-199608000-00003
Familial pancreatic cancer in south Louisiana.
T. F. Price (1996)
10.1046/J.1365-2168.1998.00641.X
Survival following pancreaticoduodenectomy with resection of the superior mesenteric–portal vein confluence for adenocarcinoma of the pancreatic head
S. Leach (1998)
10.1002/1097-0142(19811015)48:8<1705::AID-CNCR2820480803>3.0.CO;2-4
Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5‐fluorouracil), and high dose radiation + 5‐fluorouracil. The gastrointestinal tumor study group
C. Moertel (1981)



Semantic Scholar Logo Some data provided by SemanticScholar